Poseida Therapeutics Employs Dr. Syed Rizvi, M.D., as Chief Medical Officer, Navigating Share Value Decline Amid Promising Cell and Gene Therapy Advancements.
Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer; Shares Fall by 3.42% in a Challenging MarketSAN DIEGO, March 25, 2024 - Poseida Therapeutics, Inc. (Nasdaq: PSTX), a renowned clinical-stage cell...
Mar 25, 2024
• Biotechnology & Pharmaceuticals Industry
Personnel Announcements
NASDAQ
